Thursday, April 08, 2021

This one #Food #Market Grew Nearly Twice as fast as the Total US #Retail Food Market;(CSE: $RSF.C) (CSE: $EATS.C) (TSXV: $VERY.V) (TSXV: $BABY.V) (TSXV: $NEXE.V) @Rritual_IR @EatBeyondGlobal @TheVeryGoodFood @ElseNutrition @nexeinnovations

This one #Food #Market Grew Nearly Twice as fast as the Total US #Retail Food Market;(CSE: $RSF.C) (CSE: $EATS.C) (TSXV: $VERY.V) (TSXV: $BABY.V) (TSXV: $NEXE.V) @Rritual_IR @EatBeyondGlobal @TheVeryGoodFood @ElseNutrition @nexeinnovations

 

Premium #PlantBased Products Hitting Mainstream #Retail Markets  

 

Point Roberts WA, Delta, BC –April 8, 2021 - Investorideas.com, a leading investor news resource covering functional mushrooms and plant-based food alternatives releases a special report on the numerous plant-based product launches in the US and Canada, both in traditional brick and mortar retail and online sales, featuring Rritual Superfoods Inc. (CSE: RSF) (FWB: 0RW).  This growing trend speaks to the major shift in the food and beverage industry towards sustainable plant-based alternative products driven by more eco-friendly and health conscious consumerism.

 

Read this article, featuring Rritual in full at https://www.investorideas.com/news/2021/lohas/04081Plant-Based-Products-Retail-Market.asp

 

Progressive Grocer reports, “The plant-based food market grew nearly twice as fast as the total U.S. retail food market, which increased 15% in 2020 as the pandemic closed down restaurants and consumers stockpiled food while hunkering down at home. Fifty-seven percent of households now buy plant-based foods, up from 53% in 2019. The data, which PBFA and GFI commissioned from wellness-focused data technology company SPINS, was customized to target only plant-based products that directly replace animal-based products.”

 

Rritual Superfoods Inc. (CSE: RSF) (FWB: 0RW), a functional superfood company that creates plant-based elixirs which support immunity, focus and relaxation, recently announced that the Company's premium brand of functional superfoods will launch in Rite-Aid stores throughout the USA in Q2 and Q3.

 

"This first national retail rollout is a major achievement for the Rritual brand. It validates both supply and demand for the category, specifically our product quality and the rapidly growing interest of consumers in functional superfoods," said Mr. David Kerbel, Rritual Superfoods CEO.

 

"We are striving to not only lead this emerging category, but to define it. A significant part of achieving that goal is accomplished through gaining the trust and support of consumers through top tier retailers such as Rite-Aid."

 

Rritual has scaled its production to meet growing demand, with a strategic sales and marketing focus aimed at major retailers across the USA in 2021. The Rite-Aid rollout will be phased toward reaching 1000 retail stores, in addition to Rite-Aid's ecommerce platform. Rritual's retail strategy is disruptive. The Company is aiming at national retailers rather than regional rollouts in order to gain market share and category defining leadership.

 

Rite-Aid will carry Rritual's full product line, including:

       Chaga IMMUNE with adaptogens Eleuthero Root and Astragalus to support healthy immune function and well-being all year round.

       Lion's Mane FOCUS with adaptogens Rhodiola Rosea Root and Bacopa to support brain health and cognitive function.

       Reishi RELAX with adaptogen Ashwagandha and cacao to help the body adapt to stress.

 

Rritual product offerings are all USDA-certified organic and are a caffeine-free option that can be mixed with other beverages or enjoyed by itself. Rritual's proprietary Immune-Synergy Six Mushroom Blend is the only functional health product on the market that contains a daily prebiotic blend which nourishes a healthy gut microbiome and facilitates balanced digestive function.

 

David Kerbel, CEO of Rritual Superfoods Inc. in an interview recently discussed Rritual Superfoods line of functional mushroom and adaptogen formulations, as well as the growing 'Superfoods' and 'Functional Foods' categories as a whole.

 

According to Grandview Research, "The global superfoods market size was estimated at USD 137.0 billion in 2018 and is projected to ascend at a CAGR of 7.9% over the forecast period. Growing consumer interest in a healthy diet and wellness benefits has led to a thriving food & beverage industry in the recent past and this trend is expected to continue over the forecast period. This, in turn, is projected to propel the demand for superfoods in the coming years."

 

ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF), a plant-based baby, toddler and children’s nutrition company, is also upping distribution, having recently announced that it has signed a distribution agreement with US-based Imperial Distributors of Worcester, Massachusetts. Imperial is recognized throughout the Northeast, South Atlantic and Midwest United States as a leader in distribution, merchandising and category management.

 

"Partnering with Imperial distribution offers a regional view and a strategic relationship with several regional mid-tier and key accounts in New England and beyond. They're indeed a distribution leader throughout the Northeast and Mid-Atlantic states," said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. "We look forward to Imperial playing a key role in our growth in this core region, commencing with Big Y in April of this year," she added.

 

This follows their previous announcement of rolling out its Plant-Based Complete Nutrition for Toddlers at over 100 Raley's, Bel Air Markets and Nob Hill Foods locations in Northern California and Nevada in April 2021.

 

"This marks excellent distribution growth for our organization. We've decided to strategically secure rapid coverage in the Northern California and Nevada regions, and this listing with Raley's greatly advances us on this path," said Ms.Yitzhak. "Raley's maintains a family-owned culture with a true understanding and commitment to the customer experience. They have championed health and wellness for generations and are helping to change the way people eat. This aligns with the Else mission of bringing sustainable, better-for-you, balanced nutrition solutions and touching lives in a meaningful way."

 

Eat Beyond Global Holdings Inc. (CSE: EATS) (OTC: EATBF), the first fund in Canada focused on investing in global companies that are developing and commercializing innovative food products including alternatives to meat, seafood, eggs, and dairy, recently announced the success of its recent investment in The Very Good Food Company Inc. (TSXV: VERY) at a price of $0.25 per Common Share.

 

The Very Good Food Company Inc. is an emerging plant-based food technology company that designs, develops, produces, distributes and sells a variety of plant-based meat and other food alternatives. Their mission is to employ plant-based food technology to create products that are delicious while maintaining a wholesome nutritional profile and to date they have developed a core product line under The Very Good Butchers brand.

 

VGF completed its initial public offering including the full exercise of the over-allotment option by the agent for the Offering, Canaccord Genuity Corp., led by Portfolio Manager and Investment Advisor, Cary Pinkowski, resulting in the issuance of 16,100,000 common shares of the Company at a price of $0.25 per Common Share for gross proceeds of $4,025,000.

 

“We are thrilled to see The Very Good Food Company, another major plant-based IPO, mirroring the success of Beyond Meat. There is clearly extraordinary confidence in this market, and enormous demand for plant-based products,” said Patrick Morris, CEO of Eat Beyond. “We are excited to continue investing in this growing sector and continuing to be a part of more success stories like this one.”

 

This follows Eat Beyond Global Holdings Inc.'s more recent announcement that it has been selected as one of just 21 companies worldwide to be included in the VegTech™ Index.

 

The VegTech™ Index is the first index of its kind and includes leading publicly traded plant-based companies. The goal is to provide a fiscal scoreboard using market cap-weighted performance to show the overall financial health and strength for the sector.

 

"Investors can always look at the Dow Jones or NASDAQ for a look at general market numbers and averages for major companies," Morris said. "But this new index is a great opportunity for investors and analysts to be able to access a snapshot of the growing plant-based and alternative food market specifically."

 

NEXE Innovations Inc. (TSXV: NEXE) (OTC: NEXNF), a leader in plant-based compostable technology and advanced materials manufacturing based in British Columbia, Canada, is going a slightly different route to market, having recently announced launching its highly anticipated Xoma Superfoods eCommerce store.

 

The company has developed one of the only patented, fully compostable, plant-based, single-serve coffee pods for use in leading single-serve coffee machines. The proprietary NEXE pod is designed to reduce the significant environmental impact caused by single-serve pods, >40 billion of which are discarded every year. With over $30M raised to date from equity and government funding and over five years of R&D, NEXE is well-positioned to meet the growing demand for environmentally friendly and sustainable products in the single-serve coffee sector and beyond

 

Xoma Superfoods is NEXE's in-house coffee and superfoods brand, launching with a line of high-quality coffees packaged exclusively in single serve, fully compostable, plant-based NEXE pods. XOMA capsules work in Keurig single-serve brewing systems and are now available in 12-count.

 

"Xoma products provide convenience, making it easy to integrate more superfoods into your diet without creating additional waste, or making a mess of your kitchen," said Ash Guglani, President of NEXE. "We have spent five years developing our NEXE pod, and we are proud to launch it into the market with our Xoma Superfood coffees."

 

"This is a major milestone for NEXE and Xoma. Our initial pilot launch of our 3-count packages of Xoma Coffee fortified with MCT sold out within 24 hours," he continued. "Our customers have patiently waited for this day, and we are very excited to fully launch."

 

NEXE pods are fully compostable and meet international standards for certification as compostable materials, without the need to disassemble the pod after use. Over 40 billion petroleum-based single-serve coffee pods end up in landfills around the world every year, where they can take hundreds or thousands of years to break down.

 

According to one recent article, “The plant-based category has evolved to the point that retailers can’t limit who they consider the plant-based shopper,” said Dawn Vanlandingham, head of retail for SPINS. “They should now assume everyone is a potential plant-based buyer and educate them enough to see the possibilities. Between the innovation in plant-based products and the gradual return to less restrictive shopping measures, 2021 offers many opportunities for retailers to appeal to more customers and expand their plant-based offerings.”

 

Looking at how this translates to investing, Good Food Institute reported,“This strong growth in retail sales is a welcome compliment to equally impressive growth in investment dollars in the plant-based space. A record $2.1 billion was invested in plant-based food companies in 2020, highlighting growing interest in plant-based foods from both consumers and investors.”

 

Whether you are looking at functional mushrooms, plant-based meat and dairy alternatives, medicinal mushrooms and cannabinoid medications, fungal soil and waste remediation or even hemp and plant-based textiles and plastics, it is clear the age of plants is upon us. 

 

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring RSF is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Contact Investorideas.com

800-665-0411

 

 

Health, Wellness and Sustainability Stocks Research and News at Investorideas.com - investing ideas for a better world

Like Health, Wellness and Sustainability Stocks? View our LOHAS Stocks Directory

 

 

 

 

 



 

 

#AI #Health #Stock News: GBT (OTCPINK: $GTCH) Completed Prototype Design of its Long-Range Radio Mobile System; #Artificialintelligence

 #AI #Health #Stock News: GBT (OTCPINK: $GTCH) Completed Prototype Design of its Long-Range Radio Mobile System; #Artificialintelligence

 


SAN DIEGO, CA April 8, 2021 -(Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT” or the “Company”), completed its prototype design of its long range radio mobile system. The prototype mobile unit will be a high-performance radio transceiver system that is designed for data and voice applications. It is expected to enable data and voice communication for long range applications targeting telemedicine support for the Company’s qTerm vital device including audio.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/04081Prototype-Design.asp

 

The design of the prototype mobile unit includes a transceiver targeted for systems to operate under licensed/unlicensed radio frequency bands, enabling ultra-long-range applications. The unit is designed to communicate in the HF (High Frequencies) frequencies bands to establish connection with a base unit transceiver through repeater unit(s) to reach ultra-long range. High clarity, signal reliability and security is expected to  be achieved through the implementation of advanced circuitry within the system’s components. The design includes embedded software to manage the data and audio communication including data transfer to a backend server to process data. The design also provided for the mobile unit’s design, size and interface, taking into consideration performance and mobility. The operation of the mobile unit is expected to be done via an LCD touch screen providing user’s friendly interface and ease of use. Upon getting team’s FCC certification, an extensive mobile unit’s testing will start. GBT plans to test the entire system within a large city limits and national ranges.

 

"We are glad to announce that we completed the design of our prototype long range radio mobile unit. The prototype mobile unit is a key component since it is targeted to be portable aiming to bring modern life services around the globe. The design contemplates an acceptable physical size to be carried coupled with a high-power energy source and long range capability. As the system is targeted to work with the qTerm vital device, the design contemplates users being able to send vital information to professional health authorities for quick review and recommendations. In addition, the design has incorporated a voice communication will be available to discuss further steps and actions.  We believe that in our days and age everyone should have access to modern amenities and the key is global communication. For us, the most important contribution of such system is the capability to save lives by enabling health and emergency services anywhere on earth” stated Danny Rittman, the Company’s CTO.

 

There is no guarantee that the Company will be successful in researching, developing or implementing this system.  In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product.  There is no guarantee that the Company will be successful in any or all of these critical steps. 

 

Mobile unit prototype:



 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.


Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 


  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

Wednesday, April 07, 2021

Investor Ideas #Potcasts 549, #Cannabis News and #Stocks on the Move; (CSE: $VEXT.C) (CSE: $CURA.C) (TSXV: $KHRN.V) (OTCQX: $KHRNF), (CSE: $BLO.C)

 



 

Investor Ideas #Potcasts 549, #Cannabis News and #Stocks on the Move; (CSE: $VEXT.C) (CSE: $CURA.C) (TSXV: $KHRN.V) (OTCQX: $KHRNF), (CSE: $BLO.C)

 

Delta, Kelowna, BC, April 7, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/040721-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/04071VEXT-CURA-KHRN-BLO.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it has entered into three separate purchase and sale agreements to acquire: (i) a vacant industrial facility located in Eloy, Arizona; (ii) the Company's operated indoor cultivation facility in Phoenix; (iii) and the Company's operated indoor cultivation facility in Prescott Valley (collectively, the "Transactions"). Vext will pay approximately $6.55 million in aggregate cash consideration upon the closing of the Transactions, representing the outright purchase of the Eloy facility, and deposits on the Phoenix and Prescott Valley facilities. The Company expects to enter into vendor financing arrangements for the balance of the Phoenix and Prescott Valley facilities.

 

"Arizona represents one of the most exciting growth opportunities in the U.S. cannabis market today, and by adding wholly-owned cultivation capacity, we are ensuring that Vext is positioned to maximize its share of this growth through both retail and wholesale channels," said Eric Offenberger, CEO of Vext. "With the move to adult-use legalization in January and recent expansion announcements in other industries such as semiconductor production, we expect it to become increasingly challenging to find suitable cultivation locations within proximity to key population centers. By owning and expanding our cultivation capacity, we ensure stability of supply and solid margins both for the production of our award-winning Vapen brand, and our operated dispensaries. The Transactions offer us the flexibility to sell high-quality production into the wholesale market in the short term to generate additional cash flow, while looking to accretively add to our Arizona retail footprint."

 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading international provider of consumer products in cannabis has successfully completed the previously announced acquisition of EMMAC Life Sciences Limited, the largest vertically integrated independent cannabis company in Europe, for base consideration of approximately US$50 million in cash and 17.5 million shares of Curaleaf, with additional consideration to be paid based upon the successful achievement of performance milestones. Curaleaf has simultaneously established Curaleaf International Holdings Limited in Guernsey to hold the EMMAC investment and further its European expansion.

 

To accelerate the expansion of Curaleaf International, Curaleaf has secured an investment of US$130 million from a single strategic institutional investor in exchange for 31.5% equity stake in Curaleaf International, implying a $413 million Post Money valuation, with US$80 million in cash available to spend. The subscription will fund the entire cash portion of the EMMAC acquisition consideration of US$50 million with the remaining US$80 million to be used to fund Curaleaf International's current capital expenditures plan through 2022, as well as its pipeline of potential acquisitions. This infusion of outside capital into Curaleaf International significantly accelerates Curaleaf's expansion plans in Europe by fully funding Curaleaf's cash outlay for the EMMAC acquisition and providing the capital required to support Curaleaf International's near-term European rollout. With its foreseeable expansion budget fully funded, Curaleaf's new international business can focus on executing its further European expansion.

 

Curaleaf and the strategic investor have entered into a shareholders' agreement regarding the governance of Curaleaf International pursuant to which Curaleaf will have control over operational issues as well as raising capital and the ability to exit the business. In addition, the strategic investor's stake is subject to put/call rights which permits either party to cause the stake to be bought out by Curaleaf for Curaleaf equity starting in 2025.

 

Boris Jordan, Executive Chairman of Curaleaf, stated, "The successful completion of our acquisition of EMMAC, and the formation of our new Curaleaf International business, marks a transformational launching point for our entrance into the European cannabis market. Building on our market leading position in the U.S., this transaction establishes Curaleaf as the global, pure play, cannabis market leader by revenue and geographic reach. With our single strategic institutional investor, we have set a strong foundation for Curaleaf International's future growth trajectory. On behalf of the Curaleaf Board of Directors and management team, we are thrilled to welcome Antonio Costanzo, co-founder and CEO of EMMAC, as the CEO of Curaleaf International, and the entire EMMAC team to Curaleaf."

 

The new Curaleaf International platform includes cultivation, EU GMP-certified processing, distribution, and R&D operations across several key European medical cannabis markets, including the United Kingdom, Germany, Italy, Spain and Portugal. Terra Verde, Curaleaf International's European market cultivation facility in Portugal, is one of the oldest licensed cannabis growing facilities in Europe with approximately 2 hectares of cultivation area and is an industry leader on the cannabis production cost efficiency front. The Portugal based cultivation facility provides Curaleaf International with the potential to serve customers across key European medical cannabis markets as well as supporting exports to countries such as Israel, among others. Curaleaf International plans to significantly increase its cultivation capacity in 2021, and to exceed 10 tons per year by 2022, in order to accommodate future growth related to the expansion of access to cannabis across the major European medical and adult-use, as well as export markets. Curaleaf International also has an operational presence and partnerships in European Union countries that are enacting new medical cannabis access programs. Curaleaf International will also serve as the platform for other possible acquisitions in Europe and adjacent areas, and for its participation in pilot adult use programs.

 

Joseph Bayern, CEO of Curaleaf, commented, "As the consumer and political liberalization trends around cannabis that are sweeping the U.S. are increasingly taking hold across Europe, our expansion into the international cannabis market presents tremendous new long-term growth opportunities for Curaleaf. With the European population of nearly 748 million, the potential European addressable market is more than twice the size of the U.S. addressable market. With the ability to operate our new European business across country borders, with one or two cultivation sites and one manufacturing center to serve the entire region in most cases, combined with our ability to leverage the strength of our consumer packaged goods strategies and innovations from our U.S. operations, we see enormously positive implications for our ability to quickly and efficiently scale the business across Europe."

 

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, provided an operational update with regards to its supply of EU-GMP medical cannabis products to the UK. To help alleviate bottlenecks and stock outs, the Company has established an offshore inventory of dried flower, for the express purpose of serving UK patients.

 

Furthermore, the Company is broadening its product portfolio by introducing Khiron 1/14, a high-CBD flower to the UK in Q2/21. This follows a successful launch in Germany, where it is prescribed for indications such as anxiety, substance use disorder, and migraines. Khiron 1/14 will complement Khiron 20/1, a high-THC flower, which is already being prescribed to patients in the UK. Prescribing specialists will also be able to prescribe smaller quantities of our flower products in 5- gram jars (pictured below), thanks to enhanced capabilities at the Company's EU-GMP certified fulfillment partner.

 

Tejinder Virk, President of Khiron Europe, commented, "The European market is growing and Khiron is well positioned through our differentiated education platform, mounting clinical evidence, and EU-GMP certified products ready for prescription. Our team continues to work diligently to increase patient access to medical cannabis products, and patients will now benefit through greater product variety and volumes. In the coming months, we plan to introduce additional cannabis-based medical products from our registered Colombian strains, elevating the level of clinical data available to medical professionals in the UK."

 

Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF), developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, reported that it will begin beta testing its THC Breath Analyzer (“THCBA”) with a private drug testing clinic located in the Northwestern United States. Cannabix expects to deliver its version 3.0 THCBA prototype to this clinic in the coming weeks to begin a breath testing with select patients. The Company and the clinic have entered into a non-disclosure agreement. The collaborating clinic has a robust drug testing operation and is one of the top drug testing providers to employers within its respective state. The high-volume clinic has a diverse range of patients and focuses on private sector testing for alcohol and illicit drugs. The clinic has extensive experience beta testing with new drug testing technologies. In the recent past, the collaborating clinic was selected to be an early tester of oral swab devices, which have been authorized for use in certain jurisdictions.   

 

Beta-testing of the THCBA prototype will be focused on training the device’s machine learning database, to help determine sensitivity ranges and improving user and administrator experience. Furthermore, this data will help with identifying cross-reactivity of other substances with the study population. The THCBA is a drug screening device for employers and other markets who are seeking a way to quickly, easily and non-invasively test for recent use of ∆9-tetrahydrocannabinol (“THC”) - the psychoactive component of marijuana that causes impairment.

 

Current forms of testing for marijuana use can identify THC ranging from minutes to days prior to actual use, making it difficult to show the difference between the two.  Studies¹ have shown that breath is a better indicator of impairment than saliva and urine because THC is present in breath for a relatively short period of time (1-3 hours); whereas, it is excreted at detectable levels in other body fluids for many hours, days, or even weeks after smoking. This short time period of detection in breath aligns with the peak impairment window.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory